Eudragit-E

a cationic polymer, used as a embolic material for arteriovenous malformations and as a taste masker

Also Known As:

basic methacrylate copolymer; poly(butylmethacrylate-co-(2-dimethylaminoethyl)methacrylate-co-methyl methacrylate)

Networked: 9 relevant articles (2 outcomes, 0 trials/studies)

1.	Chen, K S: 2 articles (11/2001 - 09/2000)
2.	Lin, S Y: 2 articles (11/2001 - 09/2000)
3.	Run-Chu, L: 2 articles (11/2001 - 09/2000)
4.	Barroso, Paola A: 1 article (05/2021)
5.	Bracamonte, Ma Estefanía: 1 article (05/2021)
6.	Carrer, Dolores C: 1 article (05/2021)
7.	Guzman, Ma Laura: 1 article (05/2021)
8.	Marco, J Diego: 1 article (05/2021)
9.	Olivera, Ma Eugenia: 1 article (05/2021)
10.	Peralta, Ma Florencia: 1 article (05/2021)

1.	Cutaneous Leishmaniasis 05/01/2021 - "Efficacy of topical risedronate and risedronate - Eudragit E complex in a model of cutaneous leishmaniasis induced by Leishmania (Leishmania) amazonensis."
2.	Colitis 01/01/2011 - "The efficacy of the optimized formulation (containing 50% lactulose coated with Eudragit E (30% w/w) and Eudragit FS 30D (12% w/w)) was evaluated against 2, 4, 6-trinitrobenzenesulfonic acid (TNBS)-induced colitis in rats. "
3.	Arteriovenous Malformations (Arteriovenous Malformation) 01/01/2015 - "Endovascular embolization of brain arteriovenous malformations with Eudragit-E." 05/01/1996 - "A cationic polymer, Eudragit-E, as a new liquid embolic material for arteriovenous malformations." 05/01/1996 - "We have developed a new liquid material for embolisation of arteriovenous malformations: a mixture of methyl and butyl methacrylate, plus dimethylaminoethyl methacrylate copolymer (Eudragit-E) in a solvent consisting of ethanol and iopamidol. "
4.	Weight Loss (Weight Reduction) 09/03/2000 - "Weight loss of the Eudragit E film plasticized with triacetin or DEP was more pronounced with aging, but when plasticized with DBP or TBC weight loss was not seen. "
5.	Weight Gain 03/01/2003 - "At Eudragit E coating levels of 4%, 8% and 12% (coating weight gain), the onset of in vivo drug release occurred 5.5 (+/- 1.9) h. "

1.	Lactulose (Duphalac)
2.	Acids
3.	Risedronic Acid (Actonel)
4.	methylmethacrylate-methacrylic acid copolymer
5.	Iopamidol (Isovue)
6.	Ethanol (Ethyl Alcohol)
7.	Triacetin
8.	Solvents
9.	Polymers
10.	Methacrylates